Inflammation in the pathogenesis of ischemic stroke

Frontiers in Bioscience - Landmark

Volumn 20, Issue 4, 2015, Pages 772-783

  Pei, Jian ^a   You, Xiaoxin ^a   Fu, Qinghui ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

IL 17A; Ischemic stroke; Review; Tregs

Indexed keywords

AUTACOID; CYTOKINE;

BLOOD; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMAN; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

BRAIN ISCHEMIA; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; STROKE;

EID: 84918838539     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4336     Document Type: Article

References (87)

1. Towfighi A, Saver JL: Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke 42(8),2351-5 (2011). DOI: 10.1161/STROKEAHA.111.621904
2. Senelick Richard C, Rossi, Peter W, Dougherty, Karla: Living with Stroke: A Guide for Families. Contemporary Books, Chicago. (1994) No doi was found.
3. National Institute of Neurological Disorders and Stroke (NINDS): Stroke: Hope Through Research. National Institutes of Health. (1999) No doi was found.
4. Sims NR, Muyderman H: Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 1802(1), 80-91 (2010). DOI: 10.1016/j.bbadis.2009.09.003
5. Flynn RW, MacWalter RS, Doney AS: The cost of cerebral ischaemia. Neuropharmacology 55(3),250-6 (2008). DOI: 10.1016/j.neuropharm.2008.05.031
6. Lakhan SE, Kirchgessner A, Hofer M: Inflammatory mechanisms in ischemic stroke, therapeutic approaches. J Transl Med 7,97 (2009). DOI: 10.1186/1479-5876-7-97
7. Coyle JT, Puttfarcken P: Oxidative stress, glutamate, and neurodegenerative disorders. Science 262(5134),689-95 (1993). DOI: 10.1126/science.7901908
8. Ruleva NIu, Kuzin VM, Martynov MIu, Kamchatnov PR, Liukova TK, Chugunov AV, et al: Markers of inflammation, autoantibodies to neurospecific antigens and outcome in patients with acute ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova (Suppl 12),60-5 (2004). No doi was found.
9. Bernard TJ, Fenton LZ, Apkon SD, Boada R, Wilkening GN, Wilkinson CC, et al: Biomarkers of hypercoagulability and inflammation in childhood-onset arterial ischemic stroke. J Pediatr 156(4),651-6 (2010). DOI: 10.1016/j.jpeds.2009.10.034
10. Skvortsova VI, Nasonov EL, Zhuravleva EIu, Grivennikov IA, Arsen'eva EL, Sukhanov II, et al: Clinico-immunobiochemical monitoring of factors of focal inflammation in the acute period of hemispheric ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova 99(5),27-31 (1999). No doi was found.
11. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B: Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 5,46 (2008). DOI: 10.1186/1742-2094-5-46
12. Lambertsen KL, Meldgaard M, Ladeby R, Finsen B: A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab 25(1),119-35 (2005). DOI: 10.1038/sj.jcbfm.9600014
13. Zaremba J, Losy J: Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104(5),288-95 (2001). DOI: 10.1034/j.1600-0404.2001.00053.x
14. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A: Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110(3),492-9 (1997). DOI: 10.1046/j.1365-2249.1997.4621483.x
15. Nakase T, Yamazaki T, Ogura N, Suzuki A, Nagata K: The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci 271(1- 2),104-9 (2008). DOI: 10.1016/j.jns.2008.03.020
16. Yoon JS, Lee JH, Tweedie D, Mughal MR, Chigurupati S, Greig NH, Mattson MP: 3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation. J Neurosci Res 91(5),671-80 (2013). DOI: 10.1002/jnr.23190
17. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G: Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14(33),3574-89 (2008). DOI: 10.2174/138161208786848739
18. Um JY, Rim HK, Kim SJ, Kim HL, Hong SH: Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice. PLoS One 6(12),e29524 (2011). DOI: 10.1371/journal.pone.0029524
19. Zhang Z, Chopp M, Goussev A, Powers C: Cerebral vessels express interleukin 1beta after focal cerebral ischemia. Brain Res 784(1-2),210-7 (1998). DOI: 10.1016/S0006-8993(97)01317-6
20. Hillhouse EW, Kida S, Iannotti F: Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1beta in the cerebral cortex. Neurosci Lett 249(2-3),177-9 (1998). DOI: 10.1016/S0304-3940(98)00392-9
21. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ: Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 23(2-3),103-14 (1994). DOI: 10.1007/BF02815404
22. Schielke GP, Yang GY, Shivers BD, Betz AL: Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 18(2),180-5 (1998). DOI: 10.1097/00004647-199802000-00009
23. Stroemer RP, Rothwell NJ: Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J Cereb Blood Flow Metab 18(8),833-9 (1998). DOI: 10.1097/00004647-199808000-00003
24. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ: Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 21(15),5528-34 (2001). No doi was found.
25. Caso JR, Moro MA, Lorenzo P, Lizasoain I, Leza JC: Involvement of IL-1beta in acute stress-induced worsening of cerebral ischaemia in rats. Eur Neuropsychopharmacol 17(9),600-7 (2007). DOI: 10.1016/j.euroneuro.2007.02.009
26. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K: Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26(4),676-80; discussion 681 (1995). DOI: 10.1161/01.STR.26.4.676
27. Abbate A, Van Tassell BW, Biondi-Zoccai GG: Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. Bio Drugs 26(4),217-33 (2012). No doi was found.
28. Li N, He Z, Xu J, Liu F, Deng S, Zhang H: Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population. Brain Res Bull 81(1),38-42 (2010). DOI: 10.1016/j.brainresbull.2009.09.009
29. Zhang Z, Liu LJ, Zhang C, Yu YP: Association between Interleukin-1 gene single nucleotide polymorphisms and ischemic stroke classified by TOAST criteria in the Han population of northern China. Biomed Res Int 2013,961039 (2013). DOI: 10.1155/2013/961039
30. Bis JC, Heckbert SR, Smith NL, Reiner AP, Rice K, Lumley T, et al: Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis 198(1),166-73 (2008). DOI: 10.1016/j.atherosclerosis.2007.09.031
31. Tong Y, Han J, Guan X, Lu Z, Miao X, Ye J, et al: Association of IL-1 receptor antagonist gene VNTR polymorphism with ischemic stroke in the Chinese Uyghur population. Biochem Genet 51(9- 10),698-706 (2013). DOI: 10.1007/s10528-013-9599-4
32. Olsson S, Holmegaard L, Jood K, Sjögren M, Engström G, Lövkvist H, et al: Genetic variation within the interleukin-1 gene cluster and ischemic stroke. Stroke 43(9),2278-82 (2012). DOI: 10.1161/STROKEAHA.111.647446
33. Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15,797-819 (1997). DOI: 10.1146/annurev.immunol.15.1.797
34. Benveniste EN, Tang LP, Law RM: Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int J Dev Neurosci 13(3-4),341-9 (1995). DOI: 10.1016/0736-5748(94)00061-7
35. Medeiros CA, de Bruin VM, Andrade GM, Coutinho WM, de Castro-Silva C, de Bruin PF: Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke. Acta Neurol Scand 126(1),17-22 (2012). DOI: 10.1111/j.1600-0404.2011.01589.x
36. Shenhar-Tsarfaty S, Assayag EB, Bova I, Shopin L, Berliner S, Shapira I, et al: Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Thromb Res 122(2),167-73 (2008). DOI: 10.1016/j.thromres.2007.10.019
37. Spalletta G, Cravello L, Imperiale F, Salani F, Bossù P, Picchetto L, et al: Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci 25(4),255-63 (2013). DOI: 10.1176/appi.neuropsych.12120399
38. Cole JW, Brown DW, Giles WH, Stine OC, O'Connell JR, Mitchell BD, et al: Ischemic stroke risk, smoking, and the genetics of inflammation in a biracial population: the stroke prevention in young women study. Thromb J 6,11 (2008). DOI: 10.1186/1477-9560-6-11
39. Kindt TJ, Goldsby RA, Osborne BA, Kuby J: Kuby immunology. San Francisco: W.H. Freeman. p. 396. (2007). No doi was found.
40. Li L, Huang L, Vergis AL, et al: IL-17 produced by neutrophils regulates IFN-gamma- mediated neutrophil migration in mouse kidney ischemiareperfusion injury. J Clin Invest 120(1),331-342 (2010). DOI: 10.1172/JCI38702
41. Sharma AK, LaPar DJ, Zhao Y, et al: Natural killer T cell-derived IL-17 mediates lung ischemiareperfusion injury. Am J Respir Crit Care Med 183(11),1539-1549 (2011). DOI: 10.1164/rccm.201007-1173OC
42. Liesz A, Zhou W, Mracsko E, et al: Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134(Pt 3),704-720 (2011). DOI: 10.1093/brain/awr008
43. Zhao D, Hou N, Cui M, Liu Y, Liang X, Zhuang X, et al: Increased T cell immunoglobulin and mucin domain 3 positively correlate with systemic IL-17 and TNF-innodataalpha level in the acute phase of ischemic stroke. J Clin Immunol 31(4),719-27 (2011). DOI: 10.1007/s10875-011-9534-6
44. Spera PA, Ellison JA, Feuerstein GZ, Barone FC: IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251(3),189-92 (1998). DOI: 10.1016/S0304-3940(98)00537-0
45. Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, Culmsee C, et al: Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 22(10),3898-909 (2002). No doi was found.
46. Nayak AR, Kashyap RS, Purohit HJ, Kabra D, Taori GM, Daginawala HF: Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10. Inflamm Res 58(10),687-91 (2009). DOI: 10.1007/s00011-009-0036-4
47. Singh HV, Pandey A, Shrivastava AK, Raizada A, Singh SK, Singh N: Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta 419,136-8 (2013). DOI: 10.1016/j.cca.2013.02.014
48. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A: Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 110(3),492-9 (1997). DOI: 10.1046/j.1365-2249.1997.4621483.x
49. Gondek DC, Lu LF, Quezada SA, Sakaguchi S, Noelle RJ: Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforinindependent mechanism. J Immunol 174(4),1783-6 (2005). No doi was found.
50. Ormstad H, Verkerk R, Aass HC, Amthor KF, Sandvik L: Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke. J Mol Neurosci 51(3),893-902 (2013). DOI: 10.1007/s12031-013-0097-2
51. Xie G, Myint PK, Zaman MJ, Li Y, Zhao L, Shi P, Ren F, Wu Y: Relationship of serum interleukin-10 and its genetic variations with ischemic stroke in a chinese general population. PLoS One 8(9),e74126 (2013). DOI: 10.1371/journal.pone.0074126
52. Tuttolomondo A, Di Raimondo D, Forte GI, Casuccio A, Vaccarino L, Scola L, et al: Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 58(3),398-405 (2012). DOI: 10.1016/j.cyto.2012.02.012
53. Gelderblom M, Leypoldt F, Steinbach K, et al: Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40(5),1849-1857 (2009). DOI: 10.1161/STROKEAHA.108.534503
54. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 147 Suppl 1,S232-40 (2006). DOI: 10.1038/sj.bjp.0706400
55. Saleh A, Schroeter M, Ringelstein A, Hartung HP, Siebler M, Mödder U, et al: Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke. Stroke 38(10),2733-7 (2007). DOI: 10.1161/STROKEAHA.107.481788
56. Swanson RA, Ying W, Kauppinen TM: Astrocyte influences on ischemic neuronal death. Curr Mol Med 4(2),193-205 (2004). DOI: 10.2174/1566524043479185
57. Liesz A, Karcher S, Veltkamp R: Spectratype analysis of clonal T cell expansion in murine experimental stroke. J Neuroimmunol 257(1-2),46-52 (2013). DOI: 10.1016/j.jneuroim.2013.01.013
58. Yilmaz G, Arumugam TV, Stokes KY, Granger DN: Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 113(17),2105-2112 (2006). DOI: 10.1161/ CIRCULATIONAHA.105.593046
59. Hurn PD, Subramanian S, Parker SM, et al: T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 27(11),1798-1805 (2007). DOI: 10.1038/sj.jcbfm.9600482
60. Shichita T, Sugiyama Y, Ooboshi H, et al: Pivotal role of cerebral interleukin- 17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15(8),946-950 (2009). DOI: 10.1038/nm.1999
61. Kleinschnitz C, Schwab N, Kraft P, et al: Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 115(18),3835-3842 (2010). DOI: 10.1182/blood-2009-10-249078
62. Gelderblom M, Weymar A, Bernreuther C, Velden J, Arunachalam P, Steinbach K, et al: Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 120(18),3793-802 (2012). DOI: 10.1182/blood-2012-02-412726
63. Liesz A, Suri-Payer E, Veltkamp C, et al: Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 15(2),192-199 (2009). DOI: 10.1038/nm.1927
64. Ren X, Akiyoshi K, Dziennis S, et al: Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 31(23),8556-8563 (2011). DOI: 10.1523/JNEUROSCI.1623-11.2011
65. Li P, Gan Y, Sun BL, Zhang F, Lu B, Gao Y, et al: Adoptive regulatory T-cell therapy protects against cerebral ischemia. Ann Neurol 74(3),458-71 (2013). No doi was found.
66. Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, Göbel K, Schuhmann MK, et al: Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 121(4),679-91 (2013). DOI: 10.1182/blood-2012-04-426734
67. Huang Z, Yin Q, Sun W, Zhu W, Li Y, Liu W, et al: Microbleeds in ischemic stroke are associated with lower serum adiponectin and higher soluble E-selectin levels. J Neurol Sci 334(1-2),83-7 (2013). DOI: 10.1016/j.jns.2013.07.2513
68. Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, et al: Symmetric dimethylarginine predicts allcause mortality following ischemic stroke. Atherosclerosis 208,518-523 (2010). DOI: 10.1016/j.atherosclerosis.2009.06.039
69. Wanby P, Teerlink T, Brudin L, Brattstrom L, Nilsson I, Palmqvist P, et al: Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population. Atherosclerosis 185,271-277 (2006). DOI: 10.1016/j.atherosclerosis.2005.06.033
70. Brouns R, Marescau B, Possemiers I, Sheorajpanday R, De Deyn PP: Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity. Neurochem Res 34,1642-1649 (2009). DOI: 10.1007/s11064-009-9954-3
71. Worthmann H, Chen S, Martens- Lobenhoffer J, Li N, Deb M, Tryc A, et al: High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke. J Atheroscler Thromb 18,753-761 (2011). DOI: 10.5551/jat.8144
72. Chen S, Martens- Lobenhoffer J, Weissenborn K, Kielstein JT, Lichtinghagen R, Deb M, et al: Association of dimethylarginines and mediators of inflammation after acute ischemic stroke. J Neuroinflammation 9,251 (2012). DOI: 10.1186/1742-2094-9-251
73. Bongers TN, de Maat MP, van Goor ML, Bhagwanbali V, van Vliet HH, Gómez García EB, et al: High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability. Stroke 37(11),2672-7 (2006). DOI: 10.1161/01.STR.0000244767.39962.f7
74. Cojocaru IM, Cojocaru M, Burcin C: Evaluation of granulocyte elastase as a sensitive diagnostic parameter of inflammation in first ischemic stroke. Rom J Intern Med 44(3),317-21 (2006). No doi was found.
75. Matsuzawa Y, Sugiyama S, Sumida H, Sugamura K, Nozaki T, Ohba K, et al: Peripheral endothelial function and cardiovascular events in high-risk patients. J Am Heart Assoc 2(6),e000426 (2013). DOI: 10.1161/JAHA.113.000426
76. Benbir G, Ince B, Kumral E, Ongen Z, Kultursay H, Tokgozoglu L, et al: Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality. Inflammation 35(1),65-73 (2012). DOI: 10.1007/s10753-010-9290-4
77. Mishra PT, Chandra R, Saxena SK, Verma S, Jain R, Bhuyan A: High sensitivity C-reactive protein (hsCRP) level in cerebrovascular accident (stroke). JIACM 11,204-7 (2010).
78. Elkind MS: Inflammation, atherosclerosis, and stroke. Neurologist 12,140-8 (2006). DOI: 10.1097/01.nrl.0000215789.70804.b0
79. Ramos AM, Pellanda LC, Gus I, Portal VL: Inflammatory markers of cardiovascular disease in the elderly. Arq Bras Cardiol 92,221-8 (2009). No doi was found.
80. Di Napoli M, Papa F, Villa Pini Stroke Data Bank Investigators: Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in firstever ischemic stroke patients. Stroke 33(7),1763-71 (2002). DOI: 10.1161/01.STR.0000019124.54361.08
81. Cojocaru IM, Cojocaru M, Muşuroi C, Drut¸ə A, Bəcanu M: Study of some markers of inflammation in atherothrombotic pathogenesis of acute ischemic stroke. Rom J Intern Med 40(1-4),103-16 (2002). No doi was found.
82. Ding S, Zhang M, Zhao Y, Chen W, Yao G, Zhang C, et al: The role of carotid plaque vulnerability and inflammation in the pathogenesis of acute ischemic stroke. Am J Med Sci 336(1),27-31 (2008). DOI: 10.1097/MAJ.0b013e31815b60a1
83. Montecucco F, Lenglet S, Gayet-Ageron A, Bertolotto M, Pelli G, Palombo D, et al: Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. Stroke 41(7),1394-404 (2010). DOI: 10.1161/STROKEAHA.110.578369
84. Zhou J, Cheng G, Kong R, Gao DK, Zhang X: The selective ablation of inflammation in an acute stage of ischemic stroke may be a new strategy to promote neurogenesis. Med Hypotheses 76(1),1-3 (2011). DOI: 10.1016/j.mehy.2010.07.049
85. Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J: Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Hum Gene Ther 17(2),206-19 (2006). DOI: 10.1089/hum.2006.17.206
86. Kraft P, Schwarz T, Göb E, Heydenreich N, Brede M, Meuth SG, et al: The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood-brain-barrier damage, inflammation and thrombosis. Exp Neurol 247,80-90 (2013). DOI: 10.1016/j.expneurol.2013.03.026
87. Lee YS, Chio CC, Chang CP, Wang LC, Chiang PM, Niu KC, et al: Long course hyperbaric oxygen stimulates neurogenesis and attenuates inflammation after ischemic stroke. Mediators Inflamm 2013,512978 (2013). DOI: 10.1155/2013/512978